Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line

Abstract

Having appropriate in vivo and in vitro systems that provide translational models for human disease is an integral aspect of research in neurobiology and the neurosciences. Traditional in vitro experimental models used in neurobiology include primary neuronal cultures from rats and mice, neuroblastoma cell lines including rat B35 and mouse Neuro-2A cells, rat PC12 cells, and short-term slice cultures. While many researchers rely on these models, they lack a human component and observed experimental effects could be exclusive to the respective species and may not occur identically in humans. Additionally, although these cells are neurons, they may have unstable karyotypes, making their use problematic for studies of gene expression and reproducible studies of cell signaling. It is therefore important to develop more consistent models of human neurological disease.The following procedure describes an easy-to-follow, reproducible method to obtain homogenous and viable human neuronal cultures, by differentiating the chromosomally stable human neuroblastoma cell line, SH-SY5Y. This method integrates several previously described methods [1][2][3][4] and is based on sequential removal of serum from media. The timeline includes gradual serum-starvation, with introduction of extracellular matrix proteins and neurotrophic factors. This allows neurons to differentiate, while epithelial cells are selected against, resulting in a homogeneous neuronal culture. Representative results demonstrate the successful differentiation of SH-SY5Y neuroblastoma cells from an initial epithelial-like cell phenotype into a more expansive and branched neuronal phenotype. This protocol offers a reliable way to generate homogeneous populations of neuronal cultures that can be used for subsequent biochemical and molecular analyses, which provides researchers with a more accurate translational model of human infection and disease. Video LinkThe video component of this article can be found at

Flavonoids from Potentilla parvifolia Fisch. and Their Neuroprotective Effects in Human Neuroblastoma SH‐SY5Y Cells in vitro

“…SH‐SY5Y cells are a subclone of the parental neuroblastoma cell line SK‐N‐SH which contains both neuroblast‐like and epithelial‐like cells, they can be differentiated from a neuroblast‐like state into mature human neurons through a variety of different mechanisms including the use of RA, phorbol esters, and so on . The differentiated SH‐SY5Y cells represent a homogeneous neuronal population and similar to mature neurons and this makes SH‐SY5Y cells useful for a multitude of neurobiology experiments . Retinoic acid is one of the agents for inducing the differentiation of neuroblastoma cells .…”

An Immortalized Human Dorsal Root Ganglion Cell Line Provides a Novel Context To Study Herpes Simplex Virus 1 Latency and Reactivation

“…Several approaches have been advanced for studying HSV infection in human neuron-like cells in culture, including the use of human neuroblastoma cell lines (24)(25)(26) and of a differentiated human embryonal carcinoma cell line (27,28). In addition, human neurons derived from induced pluripotent stem cells (iPSCs) (29), neuronal stem cells (30), and embryonic stem cells (ESCs) (31,32) have been explored as infection models for human alphaherpesvirus.…”

Vaccinia‐related kinase 2 modulates role of dysbindin by regulating protein stability

“…It has been reported that retinoic acid can increase neurite outgrowth length by enhancing the differentiation of SH‐SY5Y cell (Shipley et al . ). The expression of VRK2 WT showed a significant reduction in the length of the longest neurite as compared with the GFP‐control in SH‐SY5Y cells, while neurite outgrowth in VRK2 KD over‐expression was partially rescued (Fig.…”